Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

ALERT: Portfolio Change

|Includes: ADMS, Amicus Therapeutics, Inc. (FOLD)

Summary

It's time to take profits on ADMS

Yesterday ADMS announces FDA Approval of GOCOVRI™ as First and Only Medication for the Treatment of Dyskinesia in Parkinson's Disease Patients just after market closed, shares up 35% after hours.

Shares up to new one-year high after announcement today.

At this point, I've decided to take profits after this huge rally and increase my holdings at FOLD with upcoming catalysts. 

My Portfolio to be updated with today's closing prices.